ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

Announcement as on 21 September 2026

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs

Announcement as on 05 August 2026

Where Will Novo Nordisk Stock Be in 3 Years?
Key PointsNovo Nordisk remains a step behind Eli Lilly in the weight loss drug market.
Announcement as on 28 July 2026

Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads
Novo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers about treatment comparisons. Lilly denies wrongdoing and stands by its advertising claims. Both companies compete in
Announcement as on 24 July 2026

Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killer
India's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disease. The approval follows a committee recommendation for adults with moderate to advanced liver fibrosis. Wegovy, cont
Announcement as on 17 July 2026

Announcements by Novo Nordisk A/s first page | Next page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 39.85
  • 12Day Average: 41.82
  • 20Day Average: 43.51
  • 50Day Average: 46
  • 100Day Average: 45.99
  • 150Day Average: 43.57
  • 200Day Average: 46.04

NVO Indicators & signals

Indicator MACD (12,26,9)

41.48, 43.43, -1.37
Indicator MACD is in negative zone

Indicator ADX (14)

53.09, 13.29, 43.36
Indicator ADX is indicating that momentum is still strong.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 43
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
24 Thu Sep 2026 38.63 37.61 to 38.72 1.21% 0.99 times
23 Wed Sep 2026 38.17 38.16 to 39.14 -3.12% 1.25 times
22 Tue Sep 2026 39.40 39.11 to 39.89 -1.05% 1.66 times
21 Mon Sep 2026 39.82 39.54 to 43.72 -7.91% 2.78 times
18 Fri Sep 2026 43.24 42.78 to 43.54 0.12% 0.7 times
17 Thu Sep 2026 43.19 41.96 to 43.44 3.55% 0.88 times
16 Wed Sep 2026 41.71 41.47 to 42.72 -1.95% 0.79 times
15 Tue Sep 2026 42.54 42.40 to 43.53 -2.07% 0.42 times
14 Mon Sep 2026 43.44 42.81 to 43.74 0.86% 0.33 times
11 Fri Sep 2026 43.07 42.72 to 43.50 -2.14% 0.75 times
10 Thu Sep 2026 44.01 44.01 to 44.82 -1.23% 0.45 times
09 Wed Sep 2026 44.56 44.52 to 45.40 -1.33% 0.6 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top